Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 15, 2015

View Archived Issues

AC Immune collaborates with Janssen on anti-Tau vaccines for Alzheimer's

Mundipharma, Purdue and Esteve join forces to develop products for pain management

Amgen collaborates with MD Anderson to develop BiTE therapies for myelodysplastic syndrome

Celgene licenses ex-U.S. rights to Agios' AG-120

MedImmune licenses Omnis Pharmaceuticals oncolytic virus therapy

Precision Biologics discloses interim survival data for NPC-1C in metastatic colorectal cancer

Drug candidate induces host-protective immune cells in visceral leishmaniasis

Novel class of antibacterial compounds targeting Mur2 ligase described

Second Genome advances SGM-1019 in phase I trial

MaRS, J&J and Janssen to advance cardiac, diabetes and depression technologies

Mersana Therapeutics expands antibody-drug conjugate collaboration with Takeda

Sarepta gives updates on two DMD trials

OncoSec Medical to initiate pilot study in triple negative breast cancer

Companies forge immuno-oncology clinical trial collaborations

Promising results presented for chimeric antigen receptors in B-cell cancer treatment

Adimab expands collaboration with GSK, establishes new agreements

Tekmira Pharmaceuticals and OnCore Biopharma confirm merger agreement

Bayer researchers prepare new BUB1 inhibitors for cancer

Scientists at Lupin disclose novel CRAC modulators

New nicotinic acetylcholine receptor modulators designed by Lupin

Seragon patent reports new ER modulators for cancer

First biosimilar insulin agent approved in Japan

FDA grants orphan drug designation to SD-809 for Tourette's syndrome in children

Hospira submits BLA for epoetin alfa biosimilar Retacrit

FDA approves medical device to treat obesity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.